Showing results (41-50 of 55) with videos related to
Sort By:
Pageof 6
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|June 22, 2016
Sex hormone-binding globulin and thrombin generation in women using hormonal contraceptionJustine Hugon-Rodin, Martine Alhenc-Gelas, H Coenraad Hemker, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 17, 2013
Low testosterone and the risk of dementia in elderly men: Impact of age and educationLaure Carcaillon, Sylvie Brailly-Tabard, Marie-Laure Ancelin, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 16, 2013
Estrogen receptor polymorphisms and incident dementia: the prospective 3C studyJoanne Ryan, Isabelle Carrière, Laure Carcaillon, et al.Plos One|March 30, 2012
Hormone treatment, estrogen receptor polymorphisms and mortality: a prospective cohort studyJoanne Ryan, Marianne Canonico, Laure Carcaillon, et al.Thrombosis Research|May 29, 2002
Association of postmenopausal hormone replacement therapy with carotid atherosclerosis and soluble thrombomodulin: the vascular aging (EVA) study. Etude du Vieillissement ArtérielLaure Petit, Floor V A van Oort, Grégoire Le Gal, et al.Contraception|February 12, 2011
Pregnane progestin contraception in systemic lupus erythematosus: a longitudinal study of 187 patientsNathalie Chabbert-Buffet, Zahir Amoura, Pierre-Yves Scarabin, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|October 17, 2009
Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort studyMarianne Canonico, Agnès Fournier, Laure Carcaillon, et al.Circulation|February 21, 2007
Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER studyMarianne Canonico, Emmanuel Oger, Geneviève Plu-Bureau, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|July 19, 2003
Differential effects of oral and transdermal estrogen/progesterone regimens on sensitivity to activated protein C among postmenopausal women: a randomized trialEmmanuel Oger, Martine Alhenc-Gelas, Karine Lacut, et al.Journal of the American Heart Association|November 7, 2012
High level of plasma estradiol as a new predictor of ischemic arterial disease in older postmenopausal women: the three-city cohort studyValérie Scarabin-Carré, Marianne Canonico, Sylvie Brailly-Tabard, et al.Pageof 6